VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.

Three-dimensional immunohistochemistry (3D-IHC) has transformed our ability to visualize the spatial arrangement of cells and molecules in intact tissues. However, traditional methods are often ...

Tsimikas, vice president of San Diego’s Scripps Whittier Diabetes Institute, helped deliver positive news for the estimated 7 million Americans who take ...

Three dimensional immunohistochemistry (3D-IHC) has transformed our ability to visualize the spatial arrangement of cells and ...

It qualifies for an EFSA health claim for foods containing oat beta-glucan that can reduce post-prandial (after ... clinical studies suggesting that oat β-glucans can reduce blood glucose and ...

What to do: Do not use glucose monitors that have not been authorized by Health Canada. Consult a healthcare professional if you have used an unauthorized glucose monitor and have health concerns.

It is well known that preventing the onset of diabetes reduces the risk of death, and that managing blood glucose levels is ...

IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announced its intention to integrate its ...

Beta Bionics, Inc. has announced plans to integrate its iLet Bionic Pancreas automated insulin delivery system with Abbott’s upcoming dual glucose-ketone sensor in the United States.

Beta thalassemia may cause mild to severe anemia, depending on the specific form of your condition. Severe anemia can cause life-threatening complications without treatment.